Bioheart, Inc. (BHRT.OB), a biotechnology company focused on the discovery, development and, subject to United States regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announces completion of the first stem cell training course to bring regenerative therapies to Australia.
http://bit.ly/1x450nA
No comments:
Post a Comment